|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：P143100 |
| 產(chǎn)品名稱：PSMA-617 |
| 產(chǎn)品CAS：1702967-37-0 |
| 規(guī)格含量：2.5mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
P143100 |
| 名稱: |
PSMVIP(LA)617 |
| 別名: |
L-Lysine, N2-[[[(1S)-1,3-dicarboxypropyl]amino]carbonyl]-N6-[3-(2-naphthalenyl)-N-[[trans-4-[[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]amino]methyl]cyclohexyl]carbonyl]-L-alanyl]-; DKFZ-PSMa-617 |
| CAS號(hào): |
1702967-37-0 |
| 分子式: |
C??H??N?O?? |
| 分子量: |
1042.14 |
| 類別: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
PSMVIP(LA)617 has been used in prostate cancer research, and is a promising prostate-specific membrane antigen-targeted theranostic agent. |
| 參考文獻(xiàn) |
|
|
|
|
?您的位置：
